| Dr David P Keating, MD | |
|
111 Colchester Ave, Dept. Of Radiology, Burlington, VT 05401-1473 | |
| (802) 847-3592 | |
| (802) 847-4822 |
| Full Name | Dr David P Keating |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 34 Years |
| Location | 111 Colchester Ave, Burlington, Vermont |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811916687 | NPI | - | NPPES |
| 1008075 | Medicaid | VT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085B0100X | Radiology - Body Imaging | 0420010253 (Vermont) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Univ. Of Vermont - Fletcher Allen Health Care | Burlington, VT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Vermont Medical Center Inc | 3779491071 | 994 |
News Archive
Beckman Coulter, Inc., a Danaher company, today announced that it has initially been awarded a contract of $1.25 million, with potential to be awarded an additional $6.5 million if all contract options are exercised, from the DRIVe (Division of Research, Innovation, and Ventures) established by the Biomedical Advanced Research and Development Authority, under the Office of the Assistant Secretary for Preparedness and Response, within the United States Department of Health and Human Services.
Rituximab (Rituxan) — a drug commonly used rheumatoid arthritis, granulomatosis with polyangiitis (formerly Wegener's), and certain types of cancers — may be a safe and effective treatment for immunoglobulin G4-related disease (commonly called IgG4-RD), according to research presented this week at the American College of Rheumatology Annual Meeting in San Diego.
Reuters reports on a new poll of health executives that indicates that the industry is not adequately prepared to protect patients' digital health records. Still, according to the Boston Globe, Dr. David Blumenthal, offered a positive view of medical technology in a Wednesday night speech, saying that electronic medical records made him a better doctor.
Altimmune, Inc., a clinical-stage biopharmaceutical company, has announced positive results from the preclinical studies conducted in mice at the University of Alabama at Birmingham of its intranasal COVID-19 vaccine candidate, AdCOVID.
A cheaper, more efficient technique for developing complex protein drugs from bacteria has been developed at the University of Sheffield.
› Verified 7 days ago
| Entity Name | University Of Vermont Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659309615 PECOS PAC ID: 3779491071 Enrollment ID: O20040406001047 |
News Archive
Beckman Coulter, Inc., a Danaher company, today announced that it has initially been awarded a contract of $1.25 million, with potential to be awarded an additional $6.5 million if all contract options are exercised, from the DRIVe (Division of Research, Innovation, and Ventures) established by the Biomedical Advanced Research and Development Authority, under the Office of the Assistant Secretary for Preparedness and Response, within the United States Department of Health and Human Services.
Rituximab (Rituxan) — a drug commonly used rheumatoid arthritis, granulomatosis with polyangiitis (formerly Wegener's), and certain types of cancers — may be a safe and effective treatment for immunoglobulin G4-related disease (commonly called IgG4-RD), according to research presented this week at the American College of Rheumatology Annual Meeting in San Diego.
Reuters reports on a new poll of health executives that indicates that the industry is not adequately prepared to protect patients' digital health records. Still, according to the Boston Globe, Dr. David Blumenthal, offered a positive view of medical technology in a Wednesday night speech, saying that electronic medical records made him a better doctor.
Altimmune, Inc., a clinical-stage biopharmaceutical company, has announced positive results from the preclinical studies conducted in mice at the University of Alabama at Birmingham of its intranasal COVID-19 vaccine candidate, AdCOVID.
A cheaper, more efficient technique for developing complex protein drugs from bacteria has been developed at the University of Sheffield.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David P Keating, MD 516 Browns Trace Rd, Jericho, VT 05465 Ph: (802) 847-3592 | Dr David P Keating, MD 111 Colchester Ave, Dept. Of Radiology, Burlington, VT 05401-1473 Ph: (802) 847-3592 |
News Archive
Beckman Coulter, Inc., a Danaher company, today announced that it has initially been awarded a contract of $1.25 million, with potential to be awarded an additional $6.5 million if all contract options are exercised, from the DRIVe (Division of Research, Innovation, and Ventures) established by the Biomedical Advanced Research and Development Authority, under the Office of the Assistant Secretary for Preparedness and Response, within the United States Department of Health and Human Services.
Rituximab (Rituxan) — a drug commonly used rheumatoid arthritis, granulomatosis with polyangiitis (formerly Wegener's), and certain types of cancers — may be a safe and effective treatment for immunoglobulin G4-related disease (commonly called IgG4-RD), according to research presented this week at the American College of Rheumatology Annual Meeting in San Diego.
Reuters reports on a new poll of health executives that indicates that the industry is not adequately prepared to protect patients' digital health records. Still, according to the Boston Globe, Dr. David Blumenthal, offered a positive view of medical technology in a Wednesday night speech, saying that electronic medical records made him a better doctor.
Altimmune, Inc., a clinical-stage biopharmaceutical company, has announced positive results from the preclinical studies conducted in mice at the University of Alabama at Birmingham of its intranasal COVID-19 vaccine candidate, AdCOVID.
A cheaper, more efficient technique for developing complex protein drugs from bacteria has been developed at the University of Sheffield.
› Verified 7 days ago
Dr. Sally Herschorn, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-3592 Fax: 802-847-4822 | |
Dr. Janusz K Kikut, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Dept. Of Radiology, Burlington, VT 05401 Phone: 802-847-3592 Fax: 802-847-4822 | |
Dr. Christopher James Anker, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 860-918-2399 | |
Dr. Mark Edgar Lach, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Fletcher Allen Health Care, Burlington, VT 05401 Phone: 802-847-5647 | |
Dr. Deborah Rubin, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-3506 | |
Bill Saliba Majdalany, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-0000 | |
Mr. Ryan Robert Walsh, Radiology Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-0000 |